| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Neogenomics, Inc. (NEO) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. NEO is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 176.4K | $2.42M | - | |
| COO | 158.9K | $2.18M | - | |
| VP | 90.5K | $1.24M | - | |
| Dir | 86.1K | $1.18M | -5,307 | |
| CEO | 38.1K | $522.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 13, 2017 | Brodie Steven G. | President, Pharma Services | Sell | 16,550 | $8.00 | $132,400.00 | -25.1% | |
| Sep 23, 2016 | Albitar Maher | Chief Medical Officer | Sell | 2,800 | $8.40 | $23,520.00 | -4.4% | |
| Sep 20, 2016 | Albitar Maher | Chief Medical Officer | Sell | 105,300 | $8.20 | $863,460.00 | -100% | |
| Sep 12, 2016 | Albitar Maher | Chief Medical Officer | Sell | 60,075 | $8.23 | $494,123.25 | -18.7% | |
| Aug 19, 2016 | Albitar Maher | Chief Medical Officer | Sale+OE | 370,000 | $8.23 | $3,045,100.00 | -58.4% | |
| May 27, 2016 | Van Oort Douglas M | Chairman And CEO | Sale+OE | 481,387 | $8.73 | $4,202,403.03 | -11.4% | |
| May 18, 2016 | Ross Steven A | CIO | Sale+OE | 18,000 | $8.50 | $153,000.00 | -80.0% | |
| May 9, 2016 | Ross Steven A | CIO | Sale+OE | 15,000 | $8.22 | $123,300.00 | -76.9% | |
| May 2, 2016 | Jones Steven C | Executive VP Of Finance | Sell | 177,745 | $8.21 | $1,459,286.45 | -5.3% | |
| Apr 29, 2016 | Ross Steven A | CIO | Sale+OE | 112,500 | $8.11 | $912,375.00 | -96.2% |